View Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
2016 DUPONT ANNUAL REPORT A world leader in science and innovation, DuPont continues to work toward sustainable, renewable and market-driven solutions for some of our biggest global challenges. We are helping to provide healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For more than two centuries, our ability to meet the changing needs of our customers and society through world-class science and innovation has been the key to our success. DuPont’s current transformation will position each of our businesses with a clear focus and allow us to deliver superior solutions and choices for our customers. For additional information about DuPont and its commitment to inclusive innovation, please visit dupont.com. 2016 SEGMENT NET SALES 2016 TOTAL SEGMENT [U.S. DOLLARS IN MILLIONS] OPERATING EARNINGS AND TOTAL SEGMENT OPERATING MARGINS [1] $147 $6,000 19.5% $2,954 19.0% $5,000 18.5% $4,000 18.0% $5,249 $9,516 $3,000 17.5% MARGIN 17.0% $2,000 $ IN MILLIONS 16.5% $1,000 $3,268 16.0% $1,960 $0 15.5% 2015 2016 $1,500 AGRICULTURE NUTRITION & HEALTH ELECTRONICS & COMMUNICATIONS PERFORMANCE MATERIALS INDUSTRIAL BIOSCIENCES PROTECTION SOLUTIONS OTHER 2016 OPERATING MARGINS BY SEGMENT 30% 25% 20% 15% 10% 5% 0% RE TRIAL ALTH 2015 US AGRICULTU PROTECTIONSOLUTIONS 2016 ELECTRONICS & IND NUTRITION & HE PERFORMANCE COMMUNICATIONS BIOSCIENCES MATERIALS Dear DuPont Shareowners, 2016 was a year of transformation and accomplishment for DuPont. We made meaningful progress improving the fundamentals of the business and significantly strengthened our competitive position, so that we started 2017 operating at a new standard of excellence. Our actions delivered strong results, while laying the foundation to drive sustainable value for shareholders over the long term. As we look ahead, we expect our continued strategic focus and discipline will advance our standing among global industry leaders. We Edward D. Breen accomplished all this while also making progress Chair of the Board & Chief Executive Officer to prepare for the next major step in the company’s 214-year history – the proposed merger of equals with The Dow Chemical Company and the intended creation of three industry-leading companies. We are also continuing DuPont’s historic Driving Performance commitment to invest in the future. When you look In 2016, we focused our efforts on increasing beyond our 2016 numbers, you see customer wins, efficiency and productivity to improve our strong execution and a robust pipeline – all results performance against metrics we identified as key of our unparalleled innovation engine. All of our to shareholder value creation. Even as we faced businesses are building on competitive positions continued macroeconomic headwinds, we drove in their markets by drawing on world-class science, progress in each of our businesses. The 2016 results technology and engineering expertise to deliver speak for themselves: the value-added solutions our customers want and need. 36% 5% In 2016, we introduced nearly 1,600 new products [2] GAAP EPS GAAP OPERATING into the marketplace, including our Pioneer® brand [4] COSTS Optimum® Leptra® hybrids, a powerful pyramid of traits that protects plant health, yield and grain 21% quality against a wide range of pests. The Optimum® OPERATING EPS[1] 11% Leptra® product lineup was one of the fastest OPERATING COSTS[1, 5] technology ramp-ups in DuPont Pioneer history and counted for nearly 70 percent of our sales in the 60 BPS[3] Brazil summer season. We also had success with our GROSS MARGINS 27% DuPont™ Zorvec™ fungicide launch, which exceeded CAPITAL SPENDING [6] expectations and will continue to drive sales in 2017. In Industrial Biosciences, our new lineup of bioactive products is serving industries ranging from food ~200 BPS and grain processing to household products. And SEGMENT OPERATING $1.6 BN in Electronics & Communications, new product MARGINS FREE CASH FLOW [1, 7] introductions in DuPont™ Solamet® paste resulted in market share gains over the prior year. [1]See inside back cover for additional information regarding these non-GAAP financial measures. [2]Generally Accepted Accounting Principles (GAAP). [3]Excludes a 70-basis-point benefit from a non-operating pension/OPEB curtailment gain. [4]GAAP operating costs defined as other operating charges, selling, general & administrative, and research & development costs. [5]Excludes significant items and non-operating pension/OPEB costs. [6]Excludes Chemours. [7]Free cash flow is defined as cash used for operating activities less purchases of property, plant and equipment. 1 Our ongoing investment in R&D and product Progress Toward Closing the Merger development continues to drive strong near- We continue to work through the regulatory review term results and strengthens our position in the process for our intended merger with Dow. Merging marketplace, while ensuring sustainable top-line our highly complementary portfolios gives us the growth for our businesses over the long term. ability to create three strong global businesses in As always, innovation remains a defining feature Agriculture, Specialty Products and Material of DuPont’s past, present and future. Science on the foundation of our combined assets, capabilities and scale. Following the merger and More Focused, Effective and Efficient subject to the approval of the DowDuPont Board, We recognize that sustainable success requires we intend to separate into three independent we are not only innovative, but also productive companies that will be industry leaders. With greater and efficient. To this end, going into 2016, we focus, each company will be able to unlock its full identified three critical priorities to help us achieve growth potential by allocating capital more effectively, best-in-class operating efficiency: cost savings, applying its powerful innovation more productively disciplined and productive capital spending, and expanding products and solutions to more and improved working capital performance. We customers worldwide. With lower cost structures and successfully executed – and in many cases exceeded increased agility, they will be better positioned to expectations – against all three. grow and thrive over the long term – reinvesting in science and innovation, delivering significant value Our continued efforts to streamline the organization for shareholders and helping customers address delivered $750 million in year-over-year cost savings, global challenges. surpassing our goal for 2016. At the same time, our capital expenditures for the year declined, We are extremely excited about the opportunities putting our capital spending back in line with in 2017 and beyond. We finished 2016 in a much depreciation and amortization. These investments stronger position than we started, with our focused on our most compelling growth projects businesses delivering on our strategic priorities and offer solid returns. We also worked to improve and generating positive momentum across the our working capital in 2016 – and set a goal for a board. We are driving growth that is rooted in the $1 billion improvement over the medium term – fundamental business model that has assured while increasing our free cash flow. DuPont’s success for more than 200 years – adapting to change, connecting science to the Each of these is a critical metric, enabling the marketplace, forging ahead in new markets and necessary investments in the business and in creating new opportunities. capital projects that will drive our long-term growth. For example, there is growing interest and Together, we are laying the foundation for a bright understanding of the benefits of probiotics today future ahead. and this market is rapidly expanding. As a leading company in this space, we are uniquely positioned Thank you for your investment in DuPont. to seize this opportunity, and we approved an investment in probiotic production facility expansion in New York and Wisconsin of more than $100 million. Edward D. Breen We will continue to keep rigorous focus in the Chair of the Board & Chief Executive Officer coming year as we build on this success and pursue new paths for growth going forward. 2 2016 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ____________________________________________________________________________ Commission file number 1-815 E. I. DU PONT DE NEMOURS AND COMPANY (Exact name of registrant as specified in its charter) DELAWARE 51-0014090 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of principal executive offices) Registrant's telephone number, including area code: 302-774-1000 Securities registered pursuant to Section 12(b) of the Act (Each class is registered on the New York Stock Exchange, Inc.): Title of Each Class __________________________________________________ Common Stock ($.30 par value) Preferred Stock (without par value-cumulative) $4.50 Series $3.50 Series No securities are registered pursuant to Section 12(g) of the Act. _____________________________________________________ Indicate by check mark whether the registrant is a well-known seasoned issuer (as defined in Rule 405 of the Securities Act). Yes No Indicate by